Search
for
Sort by
Research 961–990 of 1000+
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Lichen Planopilaris: The Alopecia We Cannot Overlook
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- New treatment modalities of alopecia areata
- Topical solutions for androgenetic alopecia: evaluating efficacy and safety
- Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- 5-Alpha-Reductase Inhibitor Treatment for Frontal Fibrosing Alopecia:A Myth or Truth?
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Folliculitis decalvans and orofacial granulomatosis
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Scalp lesions, in images
- In That Issue: Proceedings From the Third Intercontinental Meeting of Hair Research Societies
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Dermatolojik Problemler ve COVID-19
- Surgery Update for General Dermatologists Session 1
- Cutaneous Lupus Erythematosus
- Contents
- Topical Delivery of Atraric Acid Derived from Stereocaulon japonicum with Enhanced Skin Permeation and Hair Regrowth Activity for Androgenic Alopecia
- Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study
- The effect of topical finasteride in treatment of idiopathic hirsutism
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea